questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of new antimicrobial therapeutics developed by SMEs.
answerText: The United Kingdom’s 2024 to 2029 national action plan (NAP) to confront antimicrobial resistance (AMR) includes a commitment to work across sectors to develop new antimicrobials. The NAP also acknowledges the potential of alternative therapies, such as b...
heading: Antimicrobials: Small Businesses